Globe Life’s Medtronic MDT Stock Holding History

Globe Life’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-40,000	Closed	-$2.96M	–	27
2015 Q2	$2.96M	Sell	40,000 -32,000	-44%	-$2.44M	2.31%	13
2015 Q1	$5.62M	Hold	72,000	–	–	4.36%	11
2014 Q4	$5.2M	Hold	72,000	–	–	4.05%	11
2014 Q3	$4.46M	Sell	72,000 -11,000	-13%	-$699K	3.59%	12
2014 Q2	$5.29M	Sell	83,000 -10,000	-11%	-$607K	4.32%	8
2014 Q1	$5.72M	Buy	93,000 +11,000	+13%	+$641K	4.91%	6
2013 Q4	$4.71M	Hold	82,000	–	–	4.09%	9
2013 Q3	$4.37M	Hold	82,000	–	–	4.18%	9
2013 Q2	$4.22M	Buy	+82,000	New	+$4.05M	4.1%	9

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Globe Life's MDT Position: Q3 2015 in Review

Globe Life sold out of Medtronic (MDT) in Q3 2015, closing a stake of 40,000 shares — an estimated $2.96M sold.

Globe Life first reported a position in MDT in Q2 2013 and held it in 9 quarters. The position peaked at $5.72M in Q1 2014. 1,209 funds tracked by Wall St. Rank hold MDT as of Q3 2015.

Globe Life reported no remaining Medtronic position as of Q3 2015 after selling out during the quarter.
Globe Life sold 40,000 Medtronic shares in Q3 2015, an estimated $2.96M.
Globe Life first reported a position in Medtronic in Q2 2013 and held it in 9 quarters.
Globe Life's Medtronic position peaked at $5.72M in Q1 2014.
1,209 funds tracked by Wall St. Rank held Medtronic as of Q3 2015.

Based on Globe Life's 13F filing for Q3 2015, filed 10 Nov 2015.